In this study, blocking MMRN2 interaction with ligands, namely CLEC14a, in vitro and in vivo, resulted in angiostatic effect and reduced tumor implant volume, implying that binding MMRN2 with its ligand results in natively proangiogenic signaling, an understanding that is currently debated [101, 102]. Here, CLEC14A is linked to neoplasm.